Sign in

Frank I. Scott, MD MSCE

@frankiscottmd.bsky.social
843 followers 1.1K following 60 posts

Gastroenterologist specializing in IBD and epidemiology at the University of Colorado, APD of GI Fellowship program, Co-Director of GI Outcomes Research Group, Co- Director of IBD QORUS, avid philly sports fan, cyclist

PostsRepliesMedia
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 10h
very different model than the one Lactated Ringers Middle School is deploying.
010
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 01/10/2026
Excited to see this manuscript that I collaborated on with my colleague Siobhan Proksell in press! The Data Deluge: Balancing Information Overload and Evidence-Based Medicine in Gastroenterology Fellowship - Clinical Gastroenterology and Hepatology www.cghjournal.org/article/S154...
cghjournal.org
The Data Deluge: Balancing Information Overload and Evidence-Based Medicine in Gastroenterology Fellowship
The cognitive demands of gastroenterology training include countless hours studying in medical school, followed by 6 or more years of intensive on-the-job training as residents and during fellowship. ...
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 24/07/2026
"CANCLE"?
001
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 22/07/2026
Excited to be speaking in Seattle in August for AIBD Regionals: Join us August 15 and 16, 2026! #AIBDRegionals Register here: hmplink.ai/XkqP2n
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 04/07/2026
Ugh - when RATM went WOKE
040
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 12/06/2026
Excited to be part of Advances in IBD regionals this weekend in Nashville, hope to see you there! www.hmpglobalevents.com/aibdregional...
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 05/06/2026
Who knew you could take the R7 to a bears game?
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 22/05/2026
Chaotic good
010
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 30/04/2026
WWWOOOOOOOOOOOOOOOOOOOOOOO FLYERS IN OT!!
011
Reposted by Frank I. Scott, MD MSCE
CU Division of Gastroenterology and Hepatology @cugastrohep.bsky.social · 28/04/2026
Our faculty & fellows have an incredible showing at #DDW2026! 125+ presentations, including 8 symposiums, 24 abstract lectures & 17 invited talks, 70+ posters. Full CU lineup medschool.cuanschutz.edu/docs/librari... @swatipatelmd.bsky.social @bilalmohammadmd.bsky.social @frankiscottmd.bsky.social
The CU Anschutz Division of Gastroenterology and Hepatology has more than 125 presentations at Digestive Disease Week spanning across all aspects of GI and Hepatology. This is a testament to our dedication and commitment to advancing science!
052
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 21/04/2026
that cross-check/boarding absolutely should have come with a game susp.
010
Reposted by Frank I. Scott, MD MSCE
Duke GI @dukegi.bsky.social · 07/04/2026
🎙️Tomorrow, Duke GI Grand Rounds welcomes guest speaker @frankiscottmd.bsky.social , @cugastrohep.bsky.social, presenting “Optimizing Advanced Therapy Initiation and Disease Activity Monitoring in IBD.” 🎉We're beyond excited for this one and to host Dr. Scott live & in person! Join us at 8AM! #IBD
021
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 28/02/2026
Flyers just need to shoot from the blue line or farther and should eventually work out
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 19/02/2026
WHAT A MOVE WHAT A FINISH #USAHOCKEY
000
Reposted by Frank I. Scott, MD MSCE
Chris Vannini @chrisvannini.com · 19/02/2026
That pass, that move, that finish, UNBELIEVABLE
21307
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 14/02/2026
US looks kind of flat since that goal.
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 08/02/2026
Im at an ice protest….. I’m at the health club store.
181
Reposted by Frank I. Scott, MD MSCE
Carl T. Bergstrom @carlbergstrom.com · 27/01/2026
So initial experiments with Open AI's vibe-coding science tool Prism are going about as well as expected.
Rubbish paper "Is Pee Stored in the Balls" with broken diagram, broken, table, and bullshit text.
34470152
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 24/01/2026
Incredible framing here. Superb mastery of the English language. If only we had a word for when someone makes statements in opposition of clear fact
000
Reposted by Frank I. Scott, MD MSCE
Dimitri Drekonja, MD, MS @dimitridrekonja.bsky.social · 24/01/2026
Alex Pretti was a colleague at the VA. We hired him to recruit for our trial. He became an ICU nurse- I lover working with him. He was a good kind person who lived to help and these fuckers executed him. White. Hot. Rage.
13856006018633
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 10/01/2026
Starting my 48th trip around the sun with a little bit of 4am grant app review ;)
040
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 07/01/2026
Surprised I had to scroll so far to find this. Pitch perfect ending to a show that resonated with me deeply
020
Reposted by Frank I. Scott, MD MSCE
CU Division of Gastroenterology and Hepatology @cugastrohep.bsky.social · 03/12/2025
Thrilled to congratulate our incoming First-Year Fellows to the @cuanschutz.bsky.social Division of GI & Hep! 🎉We welcome this incredible lineup to @cugastrohep.bsky.social & can’t wait to work w/ these future leaders! #FutureofGI #Match2026 💪 @bilalmohammadmd.bsky.social @jchristiemd.bsky.social
022
Reposted by Frank I. Scott, MD MSCE
American Gastroenterological Association (AGA) @amergastroassn.bsky.social · 20/11/2025
Our new clinical practice guideline, published in AGA-Gastro.bsky.social, offers 16 evidence-based recommendations for treating moderate-to-severe #Crohnsdisease. Read more here: gastro.org/news/new-aga... @frankiscottmd.bsky.social #GISky
122
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
Last, what are living guidelines? 🧑🍼 🔹With how quickly drug-development 💊 and treatment strategies ♟️ change, AGA will review new lit. 📄 and update recommendations as needed every 6 months 📝. Stay tuned for updates in the future! 10/10
010
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
✳️15. For patients w/ mod-severe disease: 👍 Early advanced therapy ❌ No step-up 🪜 therapy ✳️16.🤷♂️Knowledge gap re: treating to a target of mucosal healing vs clinical remission. More data needed!
110
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
✳️13, ✳️14 For TNF + IMM therapy, should you stop? 👍 Consider stopping IMM if in steroid-free remission >6mo ❌ Don’t stop TNF Should involve shared decision making, consideration of disease severity + history, comorbidities, and risk of immunogenicity 8/10
110
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
✳️9, ✳️10, ✳️11, ✳️12 Combo therapy 💊+💊 🔹 IFX + thiopurine > IFX or thiopurine alone, particularly if no prior thiopurine use. 🤷♂️Knowledge gaps: Combo therapy with MTX, ADA+ IMM, or non-TNF biologics + IMM 7/10
100
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
✳️5, ✳️6, ✳️7.✳️ 8 Immunomodulators 💊 ❌ Thiopurines for induction 👍 Okay to use thiopurines for maintenance 👍Methotrexate SQ for induction or maintenance ❌Methotrexate PO for induction or maintenance 6/10
100
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
❗️Important❗️ 🔑High🪣or med🪣 > lower🪣 🔑 You need to factor in the patient when making tx choices, not just focus on which efficacy bucket each medication is in. Consider age 👨🦳, pregnancy status 🤰, comorbidities 🤒, functional status 👩🦽, prior med exposures, & patient preferences. 5/10
100
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
What about comparative efficacy for bio-naïve & bio-exposed? ✳️3. Bio naive: Higher 🪣> Lower 🪣 Higher🪣: IFX, ADA, VDZ, UST, RIS, MIR, GUS Lower🪣: CTP, UPA ✳️4. Exposed: Higher 🪣 or Med 🪣 > Lower 🪣 Higher🪣: ADA, RIS, GUS, UPA Med🪣: UST, MIR Lower🪣: VDZ, CTP 4/10
100
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
✳️1 & 2: What therapies are recommended compared to placebo? Strong rec: IFX, ADA, UST, RIS, GUS, MIR, UPA Conditional rec: CTP, VDZ Considerations: 1. Biosimilar = originator 2. SQ = IV 3. If severe disease, consider extended induction, dose esc, and higher maintenance doses. 3/10
100
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
📍Used GRADE framework 📍Thresholds for clinically meaningful benefits across txs: >10% vs. pbo & >5% vs. other 💊 📍For those with no prior adv tx exposure, meds were stratified into higher vs lower efficacy. For adv tx-exposed, higher-, medium-, and lower-eff. buckets were used. 2/10
100
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 20/11/2025
🚨AGA New Guideline Alert🚨 @amergastroassn.bsky.social 🔗https://smplu.link/aga_CD_guidelines ▶️AGA Living Guideline: Pharmacologic Management of Moderate-to-Severe Crohn’s Disease I’ll break down its 16 recommendations down over the next 10 tweets 🧵 👇 #AGA #GI #CD #IBD #MedTwitter 1/10
132
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 11/11/2025
Ugly game
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 08/11/2025
Forever in camp OC
020
Reposted by Frank I. Scott, MD MSCE
CU Division of Gastroenterology and Hepatology @cugastrohep.bsky.social · 06/11/2025
🎉 Congrats @frankiscottmd.bsky.social & @benclickmd.bsky.social on their updated systematic review & network meta-analysis informing the 2025 @amergastroassn.bsky.social Clinical Guidelines on the mgmt of mod-to-severe Crohn’s disease in Gastroenterology! www.gastrojournal.org/article/S001...
gastrojournal.org
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis
We performed an updated systematic review and network meta-analysis to inform the 2025 American Gastroenterological Association Clinical Guidelines on the management of moderate-to-severe Crohn’s dise...
022
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 03/10/2025
Appropriately so. Easily the most peripheral and unnecessary subscription I have. Garmin is my recorder, any serious analytics are happening in trainerroad or trainingpeaks. I often wonder why i still even pay for Strava, other than an easy interface for the grams.
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 30/09/2025
lotta potential cavities in that basket of cookies though. He's looking out for your future dental health
010
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 13/09/2025
Excited for the 7th annual IBD101 course, hosted by @amcollegegastro.bsky.social in Dallas, TX today! Fantastic educational program for first year gi fellows
141
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 31/08/2025
Apparently more so for some than others?
020
Reposted by Frank I. Scott, MD MSCE
CU Division of Gastroenterology and Hepatology @cugastrohep.bsky.social · 12/08/2025
Help us give a warm Colorado welcome 🌞🏔️to our newest IBD Faculty member- Dr. Siobhan Proksell! Dr. Proksell is an IBD specialist focusing on fertility & pregnancy in patients w/ IBD. Welcome to the team! @jchristiemd.bsky.social @frankiscottmd.bsky.social @benclickmd.bsky.social
Welcome new University of Colorado Division of Gastroenterology and Hepatology faculty member, Siobhan Proksell, MD! Dr. Proksell is an IBD specialist with a focus on fertility and pregnancy in patients managing IBD.
041
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 05/08/2025
Crushed, but will get over it
010
Reposted by Frank I. Scott, MD MSCE
Atoosa Rabiee @atoosarabiee.bsky.social · 08/07/2025
A new but tested and tried mentorship method 👇🏼 Near-Peer mentorship 😊 @drjessicadavis.bsky.social Thank you for spearheading the project #liversky journals.lww.com/lt/abstract/...
021
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 28/06/2025
I think the 11th edition of the newspeak dictionary is due any day now, right?
000
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 27/06/2025
Everything that is old is new again.
020
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 27/06/2025
The latest edition of the @amergastroassn.bsky.social guideline on the management of moderate-to-severe Crohn's disease is now open for public comment- 🔗 Review the draft and submit comments by July 20: ow.ly/iFkm50Wf4Q5
ow.ly
Open for public comment: AGA guideline on pharmacologic management of moderate-to-severe Crohn's disease
The American Gastroenterological Association (AGA) is the trusted voice of the GI community. AGA publishes top-tier journals, guidelines and patient education ...
172
Reposted by Frank I. Scott, MD MSCE
CU Division of Gastroenterology and Hepatology @cugastrohep.bsky.social · 16/06/2025
#TaylorKarlMD and #ThomasEnkeMD took home the Dr. Marshall Freedman Award for outstanding academic and clinical records! Recipients are chosen based on academic achievements, clinical abilities, & leadership during their fellowship. Congrats! 🎉💪 @jchristiemd.bsky.social @frankiscottmd.bsky.social
Taylor Karl, MD and Thomas Enke, MD are presented with the Dr. Marshall Freedman award by Drs. Jennifer Christie and Frank Scott.Taylor Karl, MD and Thomas Enke, MD are presented with the Dr. Marshall Freedman award by Dr. Frank Scott.
061
Frank I. Scott, MD MSCE @frankiscottmd.bsky.social · 15/06/2025
“As many, for better or worse, currently believe in microorganisms like bacteria and viruses,a focus on the humors often gets a bad rap….”
1130
Reposted by Frank I. Scott, MD MSCE
Peter Gleick @petergleick.bsky.social · 31/05/2025
There are 2 previous historical cases of countries destroying their science and universities, crippling them for decades: Lysenkoism in the USSR and Nazi Germany. The Trump administration will be the 3rd. It's not just budgets but research, institutions, expertise, and training the next generation.
Graphs showing 25 years of budgets for the National Institute of Health, NASA, and the NSF. In all cases, the proposed budget for next year is far, far below any year of the previous quarter century.
449151517826